Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

EpiTan plans IND filing for Melanotan

Nov. 13, 2003

No Comments

Clinical benefits of efalizumab in plaque-type psoriasis

Nov. 10, 2003

No Comments

New HC-PTP inhibitors and their use as wound-healing agents claimed by Ontogen

Nov. 6, 2003

No Comments

New cytochrome P-450RAI inhibitors and their use patented by Allergan

Nov. 4, 2003

No Comments

Encouraging preliminary phase II results for LyphoDerm

Oct. 31, 2003

No Comments

Raptiva approved for chronic, moderate to severe plaque psoriasis

Oct. 30, 2003

No Comments

First North American trial of Adhibit

Oct. 30, 2003

No Comments

Daivobet effective in severe psoriasis

Oct. 29, 2003

No Comments

Dual role of adenosine A2A receptor activation in wound healing

Oct. 29, 2003

No Comments

Teva to commercialize OrCel in Israel

Oct. 28, 2003

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Dermatologic
RSS

EpiTan plans IND filing for Melanotan

Clinical benefits of efalizumab in plaque-type psoriasis

New HC-PTP inhibitors and their use as wound-healing agents claimed by Ontogen

New cytochrome P-450RAI inhibitors and their use patented by Allergan

Encouraging preliminary phase II results for LyphoDerm

Raptiva approved for chronic, moderate to severe plaque psoriasis

First North American trial of Adhibit

Daivobet effective in severe psoriasis

Dual role of adenosine A2A receptor activation in wound healing

Teva to commercialize OrCel in Israel

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Dermatologic RSS

Dermatologic
RSS